Chung Shan Medical University
Taichung, South, 402, Taiwan
NCT Number: NCT06203834
The aim of this study is to investigate the effects of I-Fiber Pearl on Body Weight and Body Fat in Obese Adults.
Looking for future studies?
Notify Me20 year–50 year
Female
Interventional
Not applicable
Taichung, South, 402, Taiwan
This randomized, double-blinded,placebo-controlled clinical trial will be conduct for 12 weeks with fifty adults. Subjects will be recruited and randomly assigned into two groups: (1) placebo, n = 25; (2) I-Fiber Pearl, n=25. During the 12 weeks intervention, the subjects should take 200g placebo or 200g I-Fiber Pearl a day . The two pearl are supplied in plastic packages, and both the products taste the same. Subjects also should complete the assessment of anthropometric measurement, intestinal questionnaire , food record, urine, feces and blood collection at week 0 and week 12.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Eat 200g for once, and once a day.
Eat 200g for once, and once a day.
Time frame: Week 0, Week 12
Compared the difference of body weight between the week 12 and 0.
Time frame: Week 0, Week 12
Compared the difference of body fat between the week 12 and 0.
Looking for future studies?
Notify MeChung Shan Medical University
Other
Evaluating the Efficacy of I-fiber Pearl on Reducing Body Fat Accumulation in Obese Subjects: a Randomized, Double-blind, and Placebo-controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04519164
Body Weight, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT05004883
Body Weight, Body Weight Changes
La Jolla, California, United States
View Trial DetailsNCT06076187
Aging, Bariatric Surgery Candidate
Leuven, Flemish Brabant, Belgium
View Trial DetailsNCT06209996
Body Weight, Body Weight Changes
Hong Kong
View Trial Details